| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +2.48M | 99.2% | $12.09 | +$30M |
| Sells | 1 | -20K | 0.8% | $12.37 | -$247K |
| Net | 0 | +2.46M | 98.4% | +$29.8M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Perceptive Advisors Llc | Director | $67.2M | +$30M | +80.7% | Feb 1, 2024 |
| Christopher Morabito | Chief Medical Officer | $0 | -$247K | -100% | Apr 1, 2024 |
| Anthony Gregg Lapointe | Director | Jun 5, 2024 | |||
| Benjamin Harshbarger | Chief Legal Officer | Feb 8, 2024 | |||
| Joanne Beck | Director | Jun 5, 2024 | |||
| Jill C. Milne | CEO and President, Director | Feb 8, 2024 | |||
| Fred Callori | Director | Jun 5, 2024 | |||
| Andrea Matthews | Chief Business Officer | Feb 8, 2024 | |||
| Michael Kishbauch | Director | Jun 5, 2024 | |||
| Noah Clauser | Chief Financial Officer | Feb 8, 2024 | |||
| Jonathan Violin | Director | Jun 5, 2024 | |||
| Andrew John Nichols | Chief Scientific Officer | Mar 1, 2022 | |||
| Andrew Komjathy | Chief Commercial Officer | Feb 8, 2024 | |||
| Hugh Cole | Director | Jun 5, 2024 | |||
| Kenneth Bate | Director | Jun 5, 2024 | |||
| Sunil Agarwal | Director | Apr 8, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|